4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-15-000108
CIK 0001126234operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:22 PM ET
Size
14.7 KB
Accession
0001126234-15-000108
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
Ramsey William J.
Quality Assurance Officer
Transactions
- Exercise/Conversion
Common Stock
2015-06-01$21.38/sh+280$5,986→ 34,646 total - Sale
Common Stock
2015-06-01$42.53/sh−1,500$63,795→ 33,146 total - Sale
Common Stock
2015-06-01$42.94/sh−1,000$42,940→ 32,146 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-01−2,200→ 15,645 totalExercise: $11.79Exp: 2023-01-13→ Common Stock (2,200 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-01−280→ 31,970 totalExercise: $21.38Exp: 2024-01-01→ Common Stock (280 underlying) - Exercise/Conversion
Common Stock
2015-06-01$11.79/sh+2,200$25,938→ 34,366 total
Footnotes (6)
- [F1]Includes 3,399 shares delivered net settlement upon vesting of 5,100 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan. The RSUs became immediately vested under the terms of separation agreement entered into between the Company and the Reporting Person on May 22, 2015.
- [F2]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 1/5/2015.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.13 to $42.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.78 to $43.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
- [F5]1/4th of the shares vest on January 14, 2014, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.
- [F6]1/4th of the shares vest on January 2, 2015, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:22 PM ET
- Size
- 14.7 KB